Hikma Pharmaceuticals PLC (HKMPF)

Hikma Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 19, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,820	5,533	5,038	4,118	6,954	7,923
Market Cap Growth	13.22%	9.82%	22.33%	-40.78%	-12.23%	24.01%
Enterprise Value	6,133	6,553	6,071	5,281	7,541	8,475
Last Close Price	21.94	23.32	21.76	18.02	27.35	32.83
PE Ratio	12.99	15.41	26.52	21.91	16.52	18.38
PS Ratio	1.50	1.77	1.75	1.64	2.72	3.38
PB Ratio	1.89	2.38	2.28	1.92	2.82	3.69
P/TBV Ratio	3.65	4.79	4.59	4.07	4.46	6.29
P/FCF Ratio	13.28	13.87	11.48	10.51	14.11	27.13
P/OCF Ratio	9.15	9.81	8.29	7.77	10.90	17.08
EV/Sales Ratio	1.94	2.10	2.11	2.10	2.95	3.62
EV/EBITDA Ratio	8.06	8.33	7.62	7.88	10.50	12.96
EV/EBIT Ratio	10.75	10.78	9.71	10.61	13.44	15.70
EV/FCF Ratio	16.90	16.42	13.83	13.47	15.30	29.03
Debt / Equity Ratio	0.61	0.56	0.54	0.60	0.34	0.43
Debt / EBITDA Ratio	2.01	1.64	1.46	1.88	1.16	1.40
Debt / FCF Ratio	4.29	3.27	2.71	3.27	1.72	3.19
Asset Turnover	0.62	0.64	0.63	0.57	0.60	0.58
Inventory Turnover	1.82	1.82	1.76	1.70	1.73	1.70
Quick Ratio	0.65	0.60	0.82	1.05	1.31	1.05
Current Ratio	1.24	1.14	1.57	1.86	2.06	1.87
Return on Equity (ROE)	15.38%	15.98%	8.81%	8.28%	18.20%	20.11%
Return on Assets (ROA)	6.97%	7.75%	8.54%	7.04%	8.24%	8.37%
Return on Capital (ROIC)	9.43%	10.81%	11.44%	9.23%	10.97%	11.45%
Return on Capital Employed (ROCE)	16.60%	19.30%	18.70%	14.70%	16.70%	17.40%
Earnings Yield	7.70%	6.49%	3.77%	4.57%	6.05%	5.44%
FCF Yield	7.53%	7.21%	8.71%	9.52%	7.09%	3.69%
Dividend Yield	3.70%	3.43%	3.31%	3.11%	1.97%	1.52%
Payout Ratio	50.34%	48.75%	72.10%	66.49%	28.50%	25.29%
Buyback Yield / Dilution	0.18%	-0.51%	1.13%	3.47%	2.10%	2.06%
Total Shareholder Return	4.01%	2.92%	4.44%	6.58%	4.08%	3.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.